Clinical trial
Study Investigating Administration of Prevenar for Post-Marketing Surveillance
NCT00195390 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00195390 |
|---|---|
| Title | Study Investigating Administration of Prevenar for Post-Marketing Surveillance |
| Official title | Investigation of Prevenar (Pneumococcal 7-Valent Conjugate Vaccine) Administration for Post-Marketing Surveillance |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Pneumococcal Infections |
| Intervention type | Biological |
| Interventions | Prevenar |
| Enrollment | 600 |
| Start date | Jul 1, 2004 |
| Completion | Jul 1, 2008 |
| First posted | Sep 19, 2005 |
| Last update posted | Sep 25, 2008 |
| Countries | South Korea |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: